Arkolith/Insider Trading/TCON/Form 4

Brown Scott B.

Chief Financial OfficerTracon Pharmaceuticals, Inc. (TCON) · full profile →Form 4 · filed Mar 30, 2022
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 29, 2022Buy(P)1K$2.82$3K9K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-021567) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML